IE45967B1 - Phenoxyacetic acid derivatives - Google Patents
Phenoxyacetic acid derivativesInfo
- Publication number
- IE45967B1 IE45967B1 IE1933/77A IE193377A IE45967B1 IE 45967 B1 IE45967 B1 IE 45967B1 IE 1933/77 A IE1933/77 A IE 1933/77A IE 193377 A IE193377 A IE 193377A IE 45967 B1 IE45967 B1 IE 45967B1
- Authority
- IE
- Ireland
- Prior art keywords
- acid
- dichloro
- compound
- process according
- alkyl
- Prior art date
Links
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical class OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 title description 10
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- AGHANLSBXUWXTB-UHFFFAOYSA-N tienilic acid Chemical compound ClC1=C(Cl)C(OCC(=O)O)=CC=C1C(=O)C1=CC=CS1 AGHANLSBXUWXTB-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930192474 thiophene Natural products 0.000 claims abstract description 7
- 125000005907 alkyl ester group Chemical group 0.000 claims abstract description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- 230000018044 dehydration Effects 0.000 claims description 5
- 238000006297 dehydration reaction Methods 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- MWQVQEFJAIFHFZ-UHFFFAOYSA-N 2,3-dichloro-4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(Cl)=C1Cl MWQVQEFJAIFHFZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 claims description 4
- -1 alkyl monochloroacetate Chemical compound 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 claims description 4
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 claims description 4
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 3
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 claims description 2
- 229960003750 ethyl chloride Drugs 0.000 claims description 2
- VNWKTOKETHGBQD-YPZZEJLDSA-N carbane Chemical group [10CH4] VNWKTOKETHGBQD-YPZZEJLDSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000001882 diuretic effect Effects 0.000 abstract description 5
- RHNDEZPJQWPQJU-UHFFFAOYSA-N 4-(carboxymethoxy)-2,3-dichlorobenzoic acid Chemical compound OC(=O)COC1=CC=C(C(O)=O)C(Cl)=C1Cl RHNDEZPJQWPQJU-UHFFFAOYSA-N 0.000 abstract description 4
- 150000002148 esters Chemical class 0.000 abstract description 2
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000000203 mixture Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 238000010992 reflux Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000000155 melt Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 229960000356 tienilic acid Drugs 0.000 description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- HFEASCCDHUVYKU-UHFFFAOYSA-N 1,2-dichloro-3-methoxybenzene Chemical compound COC1=CC=CC(Cl)=C1Cl HFEASCCDHUVYKU-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 3
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 3
- 230000003424 uricosuric effect Effects 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- KRVKCQGNBBYQJK-MVNLRXSJSA-N (2r,3r,4r,5r)-hexane-1,2,3,4,5,6-hexol;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO KRVKCQGNBBYQJK-MVNLRXSJSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RBJIGQRZLITQJG-UHFFFAOYSA-N 2-(2,3-dichlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=CC(Cl)=C1Cl RBJIGQRZLITQJG-UHFFFAOYSA-N 0.000 description 1
- JYBASOYAJOAATF-UHFFFAOYSA-N 2-chloro-1-(2,3-dichloro-4-methoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CCl)C(Cl)=C1Cl JYBASOYAJOAATF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229940116731 Uricosuric agent Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003383 uricosuric agent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
2,3-Dichloro-4-(2-thenoyl)phenoxyacetic acid is a drug possessing a diuretic effect. It is prepared by acylating thiophene with 2,3-dichloro-4-carboxyphenoxyacetic acid or its alkyl ester. In the latter case, the resulting ester is hydrolysed.
Description
The present invention is concerned with processes for the preparation of 2,3-dichioro-4-(2-thenoyl)phenoxyacetic acid (tienilic acid), a diuretic and uricosuric agent used in human therapy.
French Pateiit Specification 2,058,403 describes the preparation of tienilic acid which involves the reaction of a derivative of 2-thiophenecarbdxylic acid with either 2,3-dichloroanisole or 2,3-dichlorophenoxyacetic acid in the presence of a Lewis catalyst.
According to this invention there is provided a process for the preparation of 2,3-dichloro-4-(2-thenoyl)phenoxyacetic acid and alkyl esters thereof, which comprises acylating thiophene with a compound of the formula:
(where R is hydrogen or an alkyl group and X is hydroxy or chloro) (a) in the presence of a dehydration agent when X is hydroxy and R is hydrogen or an alkyl group, or (b) in the presence of stannic chloride when X is chloro and R is an alkyl group, and if desired subjecting the product to hydrolysis when R is alkyl in the compound produced.
R is conveniently a C^-C^ alkyl group, for example an ethyl group.
The dehydration agent is polyphosphoric acid or trifluoroacetic anhydride, for example. A solvent is preferably used, for example benzene, methylene chloride or di chloroethane. The reaction is usually complete in from 1-8 hours. It is also possible to use the product of the action of phosphoric anhydride on methane sulfonic acid, as described in J. Org.
Chem. 38 4071 (1973), as the dehydration agent. However, the yields of the reaction have been lower in this latter case.
Alternatively, the compound of formula I wherein R represents an alkyl group can be converted into the corresponding acid chloride by reaction with thionyl chloride and then condensed with thiophene in the presence of stannic chloride and in a solvent such as 1-,2-dichloroethane.
- 2 45967
In the above formula I, R preferably represents an alkyl group of C-j-C^ and more particularly an ethyl group.
The compound of formula I can be prepared from 2,3-dichloroanisole by carrying out, for example, the following reactions:
Cl Cl Cl Cl
O-CHo + Cl-CHp-CO-Cl A1C13 > ci-CH„- C , O-CH, ch2ci2
I!
This sequence of reactions is described in British Patent Specification from
No. 1,568,320, and/(2,3-dichloro-4-hydroxy)benzoic acid,(2,3,-dichloro-420 carboxy)phenoxyacetic acid can be obtained for such by reaction with monochloroacetic acid in the presence of sodium hydroxide or by reaction with ethyl monochloroacetate followed by hydrolysis. It is possible to transform (Z,3-dichloro-4-carboxy)phenoxyacetic acid into its ethyl ester, which has a significantly higher solubility in organic media than the free acid, for example, by monoesterification.
(2,3-Dichloro-4-carboxy)phenoxyacetic acid, in addition to having utility as an intermediate in preparing tienilic acid has a diuretic and uricosuric activity as demonstrated in standard pharmacological procedures summarized as follows.
Diuretic and Uricosuric Activity.
The diuretic and uricosuric activity of (2,3dichloro-4-carboxy)phenoxyacetic acid is determined by intraveneous admin- 3 45967 istration to the phosphate-mannitol infused mongrel dog.
From renal clearance studies,the effect of the test compound upon kidney function is determined by measurement of effective renal plasma flow, glomerular filtration rate and filtration fraction. Urine volume, pH, electrolyte and uric acid excretion are also determined. In this study, (2,3-diehloro-4carboxy) phenoxyacetic acid at a dose of 60 mg/kg i.v. increased sodium and potassium excretion and increased uric acid filtered by 116%.
The following example illustrates the invention.
EXAMPLE
A) Preparation of (2,3-dichloro-4-methoxyphenyl) chloromethyl ketone ~ ~
g. of aluminum chloride is added in small portions to a solution, kept at 0°C., of 53 g. of 2,3-dichloroanisole and 37 g. of chloracetyl chloride in 400 ml. of methylene chloride. After 2. hours at 0°C., the mixture is kept for 12 hours at 25°C. and then poured over a mixture of ice and concentrated hydrochloric acid. The organic phase is decanted and the aqueous phase is once again extracted with chloroform. The residue obtained after evaporating the organic solvents is recrystallized in a mixture of benzene and petroleum ether (1/1) to give in 80% yield, the ketone which melts at 90°C.
B) Preparation of N-[(2,3-dichloro-4-hydroxyphenyl) carbonylmethyl) pyridinium chloride
A mixture of 231 g. of pyridine hydrochloride and 77 g. of the previously obtained ketone is kept for 10 minutes at 170°C. and then cooled to 100°C.; then 3 volumes of ice water and 10· ml. of IN aqueous solution of hydrochloric acid are added.
- 4 45867
The precipitate is isolated and then washed with boiling methanol to obtain in 75% yield, the pyridine derivative which melts higher than 250°c.
C) Preparation of (2,3-dichloro-4-hydroxy) benzoic acid
49.6 g. Of the preceding compound is suspended in 400 ml. of water containing 20 g. of sodium hydroxide and the mixture is kept at the reflux temperature until the solid has completely disappeared, i.e., about 4 hours. The solution is acidified by adding concentrated hydrochloric acid. The precipitate formed is separated out and recrystallized from dichloroethane to give in 95% yield, the acid which melts at 205°C.
D) (2,3-Dichloro-4-carboxy) phenoxyacetic acid is then prepared by the action of sodium monochloracetate on the phenol compound prepared in (C)., in the presence of sodium hydroxide in aqueous or alcoholic solution, or also by the action of ethylmonochloracetate on the compound prepared in (C) in alcohol solution, followed by hydrolysis in a basic aqueous medium.
METHOD 1
g. of (2,3-dichloro-4-hydroxy) benzoic acid is added to 100 ml. of a 3 N aqueous solution of sodium hydroxide, followed by the addition of 9.45 g. of monochloracetic acid. After 2 hours of reflux, 5 g. of sodium hydroxide and 4.7 g. of monochloracetic acid is added once again and the reflux is extended for 2 hours.
The aqueous solution is then acidified and the precipitate is filtered and recrystallized in a dioxane/water mixture (50/50) to give the acid product which melts at more than 250°C., with 70% yield.
METHOD 2
4.8 g. of (2,3-dichloro-4-hydroxy) benzoic acid is heated for 1 hour at the reflux temperature in 50 ml. of ethyl alcohol containing 2.55 g. of potassium hydroxide and 3.9 g. of potassium iodide. Then 5.9 g. of ethyl monochloracetate is added and the mixture is kept at the reflux temperature until it becomes neutral. 50 ml. of water and 5 g. of potassium hydroxide are then added and the mixture refluxed for another 1-1/2 hours. The reaction mixture is cooled, poured into water, and acidified with hydrochloric acid, separating the precipitated diacid (yield 75%).
Ethyl (2,3-dichloro-4-carboxy) phenoxyacetate is obtained by monoesterification of the diacid. Thus 20 g. of the diacid is dissolved in 250 ml. of benzene,and 250 ml. of ethyl alcohol and 1.2 ml. of concentrated sulfuric acid are added. The solution is kept at the reflux temperature for f
hours. After neutralization by adding sodium bicarbonate, the solvents are evaporated and the residue is dissolved in an aqueous solution of sodium carbonate. The aqueous phase is then acidified and the precipitate is filtered and recrysfcallized from 1,2-dichloroethane by filtering hot; the precipitate obtained melts at 166°C. (yield 50%).
E) Preparation of tienilic acid
METHOD 1:
.12 g. of ethyl(2,3-dichloro-4-carboxy)phenoxyaceta.teand 1.68 g. of thiophene are added to a mixture of 40 g. of polyphosphoric acid and 200 ml. of benzene, while vigorously agitating. The reaction mixture is kept for 10 hours at the reflux temperature of benzene and then is poured into 2 volumes of water. The benzene phase is decanted and the aqueous phase is extracted with ether. The organic phases are washed with an aqueous solution of sodium hydroxide, dried, and the solvents evaporated. 1.2 g. of ethyl 2,3-dichloro-4-(2-thenoyl) phenoxyacetateis isolated, which is hydrolyzed by the action of potassium hydroxide in ethyl alcohol at the reflux temperature in order to obtain tienilic acid with a yield of 90%.
During this reaction it is also possible to use as a solvent methylene chloride or 1,2-dichloroethane. Also, thiophene may be added in portions during the course of heating.
Furthermore, it is also possible to use the same procedural method to acylate the (2,3-dichloro-4-carboxy ) phenoxyacetio acid.
METHOD 2 g, of ethyl (2,3-dichloro-4-carboxy) phenoxy15 acetate and 30 ml. of thionyl chloride are heated 3 hours at about 80°C. Benzene is added and the liquid distilled under reduced pressure.
The crude product (2,3-dichloro-4-oarbethoxymethoxy) benzoylchloride remains as a solid, m.p. 80°C.
2.8 g. of thiophene and 8.5 g. of the acid chloride obtained above are dissolved in 100 ml. of 1,2-dichloroethane.
At about 0°C., 3.2 ml. of stannic chloride is introduced in the solution. The mixture is slowly heated to 60°C. and this temperature is maintained 2 hours. Ice water and hydrochloric acid are poured in, the organic phase decanted and the solvent from evaporated. The crude product is recrystallized / a mixture of ethanol/water (75/25) to give 6 g. of the pure ester.
Claims (13)
1, A process for the preparation of 2,3-dichloro-4-(2-thenoyl) phenoxyacetic acid and alkyl esters thereof, which comprises acylating thiophene with a compound of the formula: Cl Cl XC (where R is hydrogen or an alkyl group and X is hydroxy or chloro) a) in the presence of a dehydration agent when X is hydroxy and R is hydrogen or an alkyl group, or b) in the presence of stannic chloride when X is chloro and R is an alkyl group, and if desired subjecting the product to hydrolysis when R is alkyl in the compound produced.
2. A process according to Claim 1, where R is a C-|-C^ alkyl group.
3. A process according to Claim 1 or Claim 2, wherein the dehydration agent is polyphosphoric acid or trifluoroacetic anhydride.
4. A process according to Claim 3, wherein the reaction is carried out in the presence of a solvent.
5. A process according to Claim 4, wherein the third solvent is benzene, methylene chloride or di chloroethane.
6. A process according to Claim 1, wherein the compound of formula I is prepared by reacting (2,3-dichloro-4-hydroxy) benzoic acid with monodhloroacetic acid or an alkyl monochloroacetate, respectively, optionally followed by hydrolysis.
7. A process according to Claim 1, substantially as herein described.
8. A process for the preparation of 2,3-dichloro-4-(2-thenoyl)phenoxyacetic acid and its alkyl esters, substantially as herein described in the Example. -3 5
9. 2,3-Dichloro-4-(2-thenoyl)phenoxyacetic acid and its alkyl esters, when prepared by a process according to any of the preceding claims.
10. A compound of the formula: Cl Cl HOOC where R represents hydrogen or alkyl containing from one to four carbon 10 atoms.
11. The compound according to Claim 10, where R represents hydrogen.
12. The compound according to Claim 10, where R represents ethyl.
13. 15 Dated this 20th day of September 1982.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7628274A FR2364916A1 (en) | 1976-09-21 | 1976-09-21 | PROCESS FOR OBTAINING DICHLORO-2,3 (THENOYL-2) -4 PHENOXYACETIC ACID |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE45967L IE45967L (en) | 1978-03-21 |
| IE45967B1 true IE45967B1 (en) | 1983-01-12 |
Family
ID=9177881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1933/77A IE45967B1 (en) | 1976-09-21 | 1977-09-21 | Phenoxyacetic acid derivatives |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5340758A (en) |
| BE (1) | BE858848A (en) |
| CA (1) | CA1092132A (en) |
| CH (1) | CH632754A5 (en) |
| CS (1) | CS194693B2 (en) |
| DD (1) | DD132870A5 (en) |
| DE (1) | DE2742126A1 (en) |
| ES (1) | ES462472A1 (en) |
| FR (1) | FR2364916A1 (en) |
| GB (2) | GB1568319A (en) |
| GR (1) | GR63570B (en) |
| HU (1) | HU172875B (en) |
| IE (1) | IE45967B1 (en) |
| IL (1) | IL52881A (en) |
| IT (1) | IT1086083B (en) |
| NL (1) | NL7710353A (en) |
| PL (1) | PL200937A1 (en) |
| PT (1) | PT67035B (en) |
| RO (1) | RO72173A (en) |
| SU (1) | SU736871A3 (en) |
| YU (1) | YU222077A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2916980C2 (en) * | 1979-04-26 | 1981-06-19 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | Process for the preparation of thenoyl-phenoxyacetic acid esters |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2458520A (en) * | 1945-11-08 | 1949-01-11 | Socony Vacuum Oil Co Inc | Acylation of thiophene |
-
1976
- 1976-09-21 FR FR7628274A patent/FR2364916A1/en active Granted
-
1977
- 1977-09-01 CA CA286,003A patent/CA1092132A/en not_active Expired
- 1977-09-02 IL IL52881A patent/IL52881A/en unknown
- 1977-09-07 IT IT27349/77A patent/IT1086083B/en active
- 1977-09-14 GB GB38258/77A patent/GB1568319A/en not_active Expired
- 1977-09-14 GB GB20299/79A patent/GB1568320A/en not_active Expired
- 1977-09-14 CS CS775985A patent/CS194693B2/en unknown
- 1977-09-15 PT PT67035A patent/PT67035B/en unknown
- 1977-09-17 RO RO7791606A patent/RO72173A/en unknown
- 1977-09-19 DE DE19772742126 patent/DE2742126A1/en not_active Withdrawn
- 1977-09-19 PL PL20093777A patent/PL200937A1/en unknown
- 1977-09-19 BE BE181030A patent/BE858848A/en not_active IP Right Cessation
- 1977-09-19 GR GR54374A patent/GR63570B/en unknown
- 1977-09-20 ES ES462472A patent/ES462472A1/en not_active Expired
- 1977-09-20 JP JP11390077A patent/JPS5340758A/en active Pending
- 1977-09-20 CH CH1151177A patent/CH632754A5/en not_active IP Right Cessation
- 1977-09-20 YU YU02220/77A patent/YU222077A/en unknown
- 1977-09-20 HU HU77RO00000945A patent/HU172875B/en unknown
- 1977-09-20 DD DD7700201120A patent/DD132870A5/en unknown
- 1977-09-21 SU SU772524498A patent/SU736871A3/en active
- 1977-09-21 NL NL7710353A patent/NL7710353A/en not_active Application Discontinuation
- 1977-09-21 IE IE1933/77A patent/IE45967B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO72173A (en) | 1981-06-26 |
| DE2742126A1 (en) | 1978-08-03 |
| PL200937A1 (en) | 1978-05-22 |
| JPS5340758A (en) | 1978-04-13 |
| YU222077A (en) | 1983-02-28 |
| CA1092132A (en) | 1980-12-23 |
| DD132870A5 (en) | 1978-11-15 |
| HU172875B (en) | 1978-12-28 |
| PT67035A (en) | 1977-10-01 |
| CH632754A5 (en) | 1982-10-29 |
| GB1568320A (en) | 1980-05-29 |
| GR63570B (en) | 1979-11-20 |
| GB1568319A (en) | 1980-05-29 |
| FR2364916A1 (en) | 1978-04-14 |
| IE45967L (en) | 1978-03-21 |
| BE858848A (en) | 1978-03-20 |
| IL52881A0 (en) | 1977-11-30 |
| IT1086083B (en) | 1985-05-28 |
| PT67035B (en) | 1979-02-15 |
| ES462472A1 (en) | 1978-07-16 |
| NL7710353A (en) | 1978-03-23 |
| IL52881A (en) | 1981-05-20 |
| SU736871A3 (en) | 1980-05-25 |
| CS194693B2 (en) | 1979-12-31 |
| FR2364916B1 (en) | 1979-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4190671A (en) | Chalcone derivatives | |
| US3758506A (en) | Phenoxyacetic acid derivatives | |
| CN112679420B (en) | Preparation method of 2,5-dibromopyridine | |
| US4194003A (en) | New pyrrole derivatives, process for their preparation and therapeutic applications thereof | |
| US2734904A (en) | Xcxnhxc-nh | |
| Hartough et al. | Acylation Studies in the Thiophene and Furan Series. I. Iodine and Hydriodic Acid Catalyts | |
| Reynolds et al. | The reactions of 2, 2‐difluoro‐4‐methylnaphtho [l, 2‐e]‐1, 3, 2‐dioxaborin and its [2, 1‐e] isomer with N, N‐dimethylformamide | |
| US4675418A (en) | Process for preparing alkanoic acids or esters thereof by rearrangement of alpha-halo-ketones in protic medium and in the presence of a non-noble metal salt | |
| Riegel et al. | Pyridinium Analogs of the Pressor Amines. II. The Guaiacol Series1 | |
| IE45967B1 (en) | Phenoxyacetic acid derivatives | |
| US4219663A (en) | (2,3-Dichloro-4-carboxy)phenoxy acetic acid and esters thereof | |
| CN112851494B (en) | Preparation method of 1-pyrene butyric acid | |
| US3112337A (en) | 4-halo-3-sulfamoylbenzoic acid esters | |
| BURGER et al. | Acyl derivatives of dibenzothiophene. II | |
| Minton et al. | CXCI.—Studies in the coumaranone series. Part II. The preparation of 4-and 6-chlorocoumaran-2-ones and their conversion into 2-and 4-chloroflavonols respectively, and some derivatives of o-and p-chlorophenoxyacetic acids | |
| JPH03236362A (en) | Production of p-acetylaminophenol | |
| Abu‐Shady et al. | Experiments with khellin. I. The preparation of desmethylkhellin and some of its derivatives | |
| Dauben et al. | A Synthesis of 2-Methoxy-8, 9-dichloroacridine Utilizing the Chapman Rearrangement | |
| CA1089475A (en) | Process for the preparation of 2,3-dichloro-4-(2-thenoyl) phenoxyacetic acid | |
| CA1241336A (en) | Process for the preparation of arylalkanoic acids by oxidative rearrangement of arylalkanones | |
| JPH054386B2 (en) | ||
| CN116621804B (en) | Chemical kinetics resolution method of 5-and 6-carboxyfluorescein compound isomer | |
| JPS5817461B2 (en) | Method for producing butyrophenone derivatives | |
| Olin et al. | SYNTHESIS OF 4-PHENYL-2-ACETOTHIAZOLE. IX | |
| US3592813A (en) | 3-phenyl-9h-pyridazino(3,4-b)indoles |